Huadong Medicine Co., Ltd
000963
Rang in aandelen
#2706
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Aandeelprijs
$3.89
Marktkapitalisatie
$6.83B
Verandering (1 dag)
-2.22%
Verandering (1 jaar)
-30.58%
Land
CN
Handel Huadong Medicine Co., Ltd (000963)
Categorie
Healthcare
Winst voor Huadong Medicine Co., Ltd (000963)
Winst in Jun 2026 TTM: $604.11M
Volgens de meest recente financiële verslagen van Huadong Medicine Co., Ltd bedraagt de huidige winst van het bedrijf $604.11M. In 2024 behaalde het bedrijf een winst van $589.32M, een stijging ten opzichte van de winst van 2023, die $489.64M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Huadong Medicine Co., Ltd van 2001 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $604.11M | 5.23% |
| 2025 | $574.08M | -2.59% |
| 2024 | $589.32M | 20.36% |
| 2023 | $489.64M | 11.43% |
| 2022 | $439.43M | -1.22% |
| 2021 | $444.87M | -15.85% |
| 2020 | $528.63M | 6.07% |
| 2019 | $498.37M | 19.34% |
| 2018 | $417.61M | 16.89% |
| 2017 | $357.26M | 31.78% |
| 2016 | $271.11M | 23.98% |
| 2015 | $218.66M | 15.48% |
| 2014 | $189.36M | 21.89% |
| 2013 | $155.35M | 23.01% |
| 2012 | $126.29M | 29.91% |
| 2011 | $97.22M | 29.50% |
| 2010 | $75.07M | -9.32% |
| 2009 | $82.78M | 100.08% |
| 2008 | $41.37M | -0.62% |
| 2007 | $41.63M | 84.19% |
| 2006 | $22.60M | 31.03% |
| 2005 | $17.25M | 50.58% |
| 2004 | $11.46M | 28.58% |
| 2003 | $8.91M | -7.36% |
| 2002 | $9.62M | -15.85% |
| 2001 | $11.43M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $1.72B | 185.31% |
JP
|
|
| $930.30M | 53.99% |
CH
|
|
| $1.76B | 192.09% |
IN
|
